Status: Not yet recruiting
Safety and Pharmacokinetics of HRS-1597 Tablets in Healthy and Obese Participants: A Phase 1 Study
This is a Phase 1, single-center, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and pharmacokinetics of HRS-1597 tablets following single-dose administration in healthy participants and multiple-dose administration in obese participants, as well as the effect of food on the pharmacokinetics of HRS-1597 tablets.
Participants needed: 78
Trial details
Phase: Phase 1Age: 18-55Biological sex: AllType: InterventionalSponsor: Shandong Suncadia Medicine Co., Ltd.Updated: Sep 9, 2026Locations: 1
Eligibility criteria
Aged 18 to 55 years (inclusive), both male and female. [+2]
Smoking more than 5 cigarettes (or other nicotine-containing products) per day w... [+10]